Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 3, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,396	3,129	3,015	1,945	1,754	1,887
Market Cap Growth	113.37%	3.77%	55.05%	10.89%	-7.08%	19.79%
Enterprise Value	3,589	3,255	3,130	2,127	1,985	2,113
Last Close Price	8.19	7.51	7.27	4.72	4.33	4.66
PE Ratio	-	-	334.55	-	-	76.54
Forward PE	-	18.69	18.69	18.69	18.69	18.69
PS Ratio	18.80	13.26	10.97	6.07	6.51	5.44
PB Ratio	7.28	6.04	5.19	3.43	2.93	2.78
P/TBV Ratio	9.49	7.47	6.83	4.83	4.09	3.99
P/FCF Ratio	-	-	-	-	-	125.18
P/OCF Ratio	179.23	268.82	119.56	82.56	-	28.34
EV/Sales Ratio	19.87	13.80	11.39	6.64	7.37	6.10
EV/EBITDA Ratio	-	226.88	235.43	451.32	-	176.37
EV/FCF Ratio	-99.18	-	-	-	-	140.13
Debt / Equity Ratio	0.45	0.36	0.38	0.31	0.37	0.25
Debt / EBITDA Ratio	-	12.97	16.80	37.71	-	13.94
Debt / FCF Ratio	-	-	-	-	-	11.08
Asset Turnover	0.21	0.28	0.31	0.36	0.29	0.34
Inventory Turnover	0.99	1.18	1.57	1.62	1.31	1.48
Quick Ratio	0.47	0.43	0.58	1.01	1.06	1.89
Current Ratio	1.00	0.97	0.79	1.53	1.53	2.41
Return on Equity (ROE)	-20.35%	-13.10%	-1.48%	-7.00%	-12.53%	1.34%
Return on Assets (ROA)	-5.03%	-2.69%	-3.13%	-3.52%	-4.06%	-2.84%
Return on Capital (ROIC)	-5.98%	-3.05%	-3.57%	-3.96%	-4.53%	-3.22%
Earnings Yield	-2.56%	-1.62%	0.30%	-1.04%	-3.04%	1.31%
FCF Yield	-1.07%	-1.20%	-0.26%	-0.42%	-3.54%	0.80%
Payout Ratio	-	-	123.52%	-	-	40.83%
Buyback Yield / Dilution	14.00%	6.16%	-10.85%	0.91%	0.17%	-0.58%
Total Shareholder Return	-	6.16%	-10.85%	0.91%	0.17%	-0.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.